Pfizer $PFE+0.4% reported results today. You could say that the results beat expectations, but the revenue just missed expectations. Revenue was down from Q1 this year as sales of the Covid-19 vaccine fell 83% and revenue from the Paxlovide antiviral treatment fell 98%.
I've been buying $PFE+0.4% shares recently as they are currently at a really low price.
Do you have shares of $PFE+0.4% included in your portfolio?
Pfizer
PFECapital Structure
Market Cap
164.2B
Enterpr. Val.
232.3B
Valuation
P/E
-63.0
P/S
2.9
Somehow I'm not attracted to this company, so I'm not including
I have PFE and will probably add more. It's at a pre-covid price, which I think indicates it's undervalued. 4.5% divi yield, which is great covered by free cash is great too.